TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26112747

Group type: EXPERIMENTAL
Intervention: Collaboration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimal-group membership
Number of subjects: 0
Study: 23527506

Group type: EXPERIMENTAL
Intervention: Very brief (25-ms, masked) images of spiders
Number of subjects: 53

Group type: COMPARATOR
Intervention: Clearly visible (125-ms, unmasked) images of spiders
Number of subjects: 53

Group type: COMPARATOR
Intervention: Very brief images of flowers
Number of subjects: 53
Study: 21872140

Group type: EXPERIMENTAL
Intervention: Management guided by daily noninvasive estimated LVEDP monitoring (Group I, open)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Management based on clinical assessment alone (Group II, blinded)
Number of subjects: 50
Study: 19440075

Group type: EXPERIMENTAL
Intervention: Zolpidem extended-release 12.5 mg
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383
Study: 17684203

Group type: EXPERIMENTAL
Intervention: High-phenol olive oil (400 ppm)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-phenol olive oil (80 ppm)
Number of subjects: 21
Study: 15285208

Group type: EXPERIMENTAL
Intervention: Women's therapeutic community (TC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (C)
Number of subjects: 0
Study: 11446524

Group type: EXPERIMENTAL
Intervention: Critical pathway for treating CAP (implemented in 9 hospitals)
Number of subjects: 1743

Group type: COMPARATOR
Intervention: Conventional management of CAP (continued in 10 hospitals)
Number of subjects: 1743
Study: 9757151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 12
Study: 7533030

Group type: EXPERIMENTAL
Intervention: Doxazosin Mesylate (1 to 2 mg and from 2 to 4 mg over 45 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Doxazosin Mesylate
Number of subjects: 20
Study: 3062532

Group type: EXPERIMENTAL
Intervention: Removal of donor corneal epithelium
Number of subjects: 232

Group type: COMPARATOR
Intervention: No removal of donor corneal epithelium
Number of subjects: 232
Study: 30044899

Group type: COMPARATOR
Intervention: Amenamevir 400 mg daily for 10 days with Midazolam 7.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine 100 mg twice daily for 5 days with Amenamevir 400 mg and 1200 mg single doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritonavir 600 mg with Amenamevir 400 mg and 1200 mg single doses
Number of subjects: 0
Study: 26850023

Group type: EXPERIMENTAL
Intervention: Financial incentives for adherence to anti-psychotic medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without financial incentives
Number of subjects: 0
Study: 25916954

Group type: EXPERIMENTAL
Intervention: Full-time splint wear
Number of subjects: 83

Group type: COMPARATOR
Intervention: As-desired splint wear
Number of subjects: 83
Study: 22947249

Group type: EXPERIMENTAL
Intervention: Low-dose b240 (2 × 10^9 cells)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: High-dose b240 (2 × 10^10 cells)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (no b240)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: b240 (both doses)
Number of subjects: 300
Study: 19952772

Group type: EXPERIMENTAL
Intervention: MIN (self-monitoring minutes of MVPA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: STE (self-monitoring steps/day)
Number of subjects: 18
Study: 18977971

Group type: EXPERIMENTAL
Intervention: Mentor-implemented, violence prevention intervention (6-session problem-solving curriculum and 3 home visits with a health educator)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Comparison group received a list of community resources and 2 follow-up telephone calls
Number of subjects: 166
Study: 16809416

Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg or 500 mg, depending on body weight) three times a week for 12 months
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 12635974

Group type: EXPERIMENTAL
Intervention: Joint attention training using behavior modification procedures
Number of subjects: 0
Study: 10851674

Group type: EXPERIMENTAL
Intervention: Combined surgery and radiation therapy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 88
Study: 9417560

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 40
Study: 1535170

Group type: EXPERIMENTAL
Intervention: Sci-B-Vac 10 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sci-B-Vac 5 micrograms
Number of subjects: 20
Study: 3924081

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (Transiderm‐Nitro 5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31888575

Group type: EXPERIMENTAL
Intervention: Ecuador's Multiple Traffic Lights (MTL)
Number of subjects: 2105

Group type: EXPERIMENTAL
Intervention: Chile's Warning Labels (WL)
Number of subjects: 2105

Group type: COMPARATOR
Intervention: Mexican Guideline Daily Allowances (GDA)
Number of subjects: 2105
Study: 29734139

Group type: EXPERIMENTAL
Intervention: Web-based e-coach (e-coaching)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 83
Study: 27213837

Group type: EXPERIMENTAL
Intervention: Antiresorptive therapy (AT)
Number of subjects: 120
Study: 24636793

Group type: EXPERIMENTAL
Intervention: Weight-loss surgery
Number of subjects: 27

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 27
Study: 22956219

Group type: EXPERIMENTAL
Intervention: Lacteol (2 capsules/day) for 4 weeks
Number of subjects: 22
Study: 20417081

Group type: EXPERIMENTAL
Intervention: Tuna oil supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 18408393

Group type: EXPERIMENTAL
Intervention: s‐ICAM‐1 levels in children with malignant lymphoma
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: s‐ICAM‐1 levels in advanced stages and high-grade NHL
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: LDH levels in patients
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: s‐ICAM‐1 levels in HD
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: s‐ICAM‐1 levels in NHL patients
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: s‐ICAM‐1 levels in HD and NHL
Number of subjects: 35
Study: 16080280

Group type: EXPERIMENTAL
Intervention: Olfen Patch 140 mg diclofenac sodium (test preparation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 180 mg diclofenac epolamine plaster (reference preparation)
Number of subjects: 24
Study: 12695914

Group type: EXPERIMENTAL
Intervention: Glycerol hyperhydration (1.2 g kg(‐1) body mass glycerol mixed with 21 ml kg(‐1) body mass flavoured water)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (flavoured water of equal volume to the GLY trial)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Glycerol hyperhydration
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 10590497

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No antiarrhythmic drug therapy
Number of subjects: 0
Study: 8987192

Group type: EXPERIMENTAL
Intervention: HbOC vaccine immunization scheme and a booster dose at 15 months of age
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (non‐immunized children)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups (immunized and non‐immunized)
Number of subjects: 125
Study: 1521627

Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasonography (IOUS)
Number of subjects: 82
Study: 3881710

Group type: EXPERIMENTAL
Intervention: Single-dose cefotaxime
Number of subjects: 100

Group type: COMPARATOR
Intervention: Triple-dose cefotaxime
Number of subjects: 100
Study: 30321667

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (initial bolus dose of 2500 μg cholecalciferol followed by 100 μg cholecalciferol/d)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 30241477

Group type: EXPERIMENTAL
Intervention: High amylose maize starch (HAMS) sports oral rehydration solution
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual hydration practices (Control)
Number of subjects: 27
Study: 26671306

Group type: EXPERIMENTAL
Intervention: Transradial approach (R-PSE)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Transfemoral approach (F-PSE)
Number of subjects: 84
Study: 24588291

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: 12-Step Facilitation (TSF)
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 1726

Group type: COMPARATOR
Intervention: All modalities (CBT, TSF, MET)
Number of subjects: 1726
Study: 22305377

Group type: EXPERIMENTAL
Intervention: 450 mg valganciclovir
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 900 mg valganciclovir
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5 mg/kg intravenous ganciclovir
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 450 mg valganciclovir twice daily
Number of subjects: 10
Study: 20149971

Group type: EXPERIMENTAL
Intervention: Women with three or more children
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Women not breastfeeding
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 491
Study: 17567393

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16137822

Group type: EXPERIMENTAL
Intervention: SpeediCath hydrophilic-coated catheter
Number of subjects: 123

Group type: COMPARATOR
Intervention: Uncoated PVC catheter
Number of subjects: 123
Study: 11392580

Group type: EXPERIMENTAL
Intervention: omeprazole 40 mg once a day for 8 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: placebo for 8 weeks
Number of subjects: 52
Study: 9949676

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8064597

Group type: EXPERIMENTAL
Intervention: Piroxicam (Feldene, 20 mg daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Naproxen (Naprosyn, 1,000 mg daily)
Number of subjects: 45
Study: 3497686

Group type: EXPERIMENTAL
Intervention: Over-tube technique
Number of subjects: 102

Group type: COMPARATOR
Intervention: Free-hand technique
Number of subjects: 102
Study: 30393122

Group type: EXPERIMENTAL
Intervention: Verbal divergent thinking training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (time-delayed training)
Number of subjects: 0
Study: 26779980

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (Ultrapro)
Number of subjects: 950

Group type: COMPARATOR
Intervention: Heavyweight mesh (Prolene)
Number of subjects: 950
Study: 24923656

Group type: EXPERIMENTAL
Intervention: 1-g mesalazine suppository
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 129
Study: 23232609

Group type: EXPERIMENTAL
Intervention: Primary care intervention for late-life depression
Number of subjects: 514
Study: 21489229

Group type: EXPERIMENTAL
Intervention: EBP training program (one-day program on EBP principles and techniques)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: EBP training program
Number of subjects: 54
Study: 18830666

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Degree of extranodal extension
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Tumor grade
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Age
Number of subjects: 1084
Study: 16808181

Group type: EXPERIMENTAL
Intervention: Intrasocket Covomycin D
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (non-medicated side)
Number of subjects: 19
Study: 14558957

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (5-8 times daily)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Dobell's solution (5-8 times daily)
Number of subjects: 101
Study: 10999838

Group type: EXPERIMENTAL
Intervention: High-dose GH therapy (13 IU/m2 x day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GH receptor antagonist (B2036)
Number of subjects: 0
Study: 9059138

Group type: EXPERIMENTAL
Intervention: Sulphasalazine 2-3 g per day (n = 37)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (n = 42)
Number of subjects: 79
Study: 8448068

Group type: EXPERIMENTAL
Intervention: Isradipine sustained release (I-SRO) 5 mg AM
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isradipine sustained release (I-SRO) 5 mg PM
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6828943

Group type: EXPERIMENTAL
Intervention: Tetracycline and amphotericin B vaginal cream (Vagmycin; Squibb)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asymptomatic patients (control group)
Number of subjects: 0
Study: 30880040

Group type: EXPERIMENTAL
Intervention: High-Velocity Nasal Insufflation (HVNI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-Invasive Positive-Pressure Ventilation (NIPPV)
Number of subjects: 42
Study: 29234853

Group type: EXPERIMENTAL
Intervention: In Situ Septoplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extracorporeal Subtotal Septal Reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Self-Controlled)
Number of subjects: 0
Study: 27009022

Group type: EXPERIMENTAL
Intervention: ixmyelocel‐T
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (vehicle control)
Number of subjects: 114
Study: 24169365

Group type: EXPERIMENTAL
Intervention: Interleaved Combination Method (ICM)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Preconditioning Combination Method (PCM)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: ICM and PCM
Number of subjects: 14
Study: 22327806

Group type: EXPERIMENTAL
Intervention: Culturally tailored video promoting positive attitudes toward mammography
Number of subjects: 592

Group type: COMPARATOR
Intervention: Linguistically appropriate generic video
Number of subjects: 592

Group type: COMPARATOR
Intervention: Print media
Number of subjects: 592
Study: 20639825

Group type: EXPERIMENTAL
Intervention: Laparoscopic Appendectomy (LA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open Appendectomy (OA)
Number of subjects: 60
Study: 17110413

Group type: EXPERIMENTAL
Intervention: Vitamins C (2 g) and E (400 IU) given 2 h before a second dive
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (pre-dive)
Number of subjects: 7
Study: 19260170

Group type: EXPERIMENTAL
Intervention: Rehband cooling garment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15288288

Group type: EXPERIMENTAL
Intervention: Covered Ultraflex stent placement
Number of subjects: 209

Group type: COMPARATOR
Intervention: Single dose (12 Gy) brachytherapy
Number of subjects: 209
Study: 10983672

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 10

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 10
Study: 8782752

Group type: EXPERIMENTAL
Intervention: Adjusted-dose warfarin (INR 2.0-3.0)
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Low-intensity, fixed-dose warfarin (INR 1.2-1.5) plus aspirin (325 mg/day)
Number of subjects: 1044
Study: 1381070

Group type: EXPERIMENTAL
Intervention: Inpatient pain management programme
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Outpatient pain management programme
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 6654697

Group type: EXPERIMENTAL
Intervention: Standard Jamaican government school meal
Number of subjects: 0
Study: 30632640

Group type: EXPERIMENTAL
Intervention: MOVI‐KIDS multicomponent physical activity intervention (three weekly after‐school sessions of recreational non‐competitive PA lasting 60 minutes during one academic year, educational materials for parents and teachers, school playground modifications)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 240
Study: 28988172

Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 220

Group type: COMPARATOR
Intervention: Colloids
Number of subjects: 220
Study: 25209658

Group type: EXPERIMENTAL
Intervention: Food advertising
Number of subjects: 0
Study: 23819955

Group type: EXPERIMENTAL
Intervention: Nurse-led, home-based intervention (HBI)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 602
Study: 22087062

Group type: EXPERIMENTAL
Intervention: Doloraz(®) (100 mg ibuprofen/5 mL suspension)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Brufen(®) (100 mg ibuprofen/5 mL suspension)
Number of subjects: 24
Study: 18372254

Group type: EXPERIMENTAL
Intervention: FSH-only preparations following a low-dose step-up protocol
Number of subjects: 151

Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 151
Study: 16448799

Group type: EXPERIMENTAL
Intervention: Nursing care for depressive symptoms
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Problem solving training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nursing care
Number of subjects: 62
Study: 12850192

Group type: EXPERIMENTAL
Intervention: p53 gene therapy in combination with standard chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0
Study: 10653081

Group type: EXPERIMENTAL
Intervention: Total shoulder arthroplasty
Number of subjects: 47

Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 47
Study: 8990505

Group type: EXPERIMENTAL
Intervention: Topical R-85355
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1473919

Group type: EXPERIMENTAL
Intervention: Iopamidol administered intra-arterially
Number of subjects: 61

Group type: COMPARATOR
Intervention: Iopamidol administered intravenously
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ioxaglate administered intra-arterially
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ioxaglate administered intravenously
Number of subjects: 61
Study: 6383612

Group type: EXPERIMENTAL
Intervention: 500-mg tablet of clotrimazole
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31764454

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with high-density EEG recording
Number of subjects: 5
Study: 27913989

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 0
Study: 27120329

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Optimal medical management
Number of subjects: 18
Study: 24477835

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (5 g day(‐1) of powdered 1:0.5:0.5 leucine:isoleucine:valine)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: BCAA supplementation
Number of subjects: 46
Study: 23134831

Group type: EXPERIMENTAL
Intervention: 4% gelofusine, crystal/gel ratio 0:1
Number of subjects: 32

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch and sodium chloride injection, crystal/gel ratio 1:1
Number of subjects: 32
Study: 20370963

Group type: COMPARATOR
Intervention: Paroxetine or bupropion added to mood stabilizers
Number of subjects: 4361

Group type: EXPERIMENTAL
Intervention: Intensive psychosocial interventions
Number of subjects: 4361

Group type: COMPARATOR
Intervention: Lamotrigine, risperidone, or inositol
Number of subjects: 4361
Study: 17662528

Group type: EXPERIMENTAL
Intervention: Unaided smoking cessation (2 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 20
Study: 16305705

Group type: EXPERIMENTAL
Intervention: 5% oxygen partial pressure (n = 65)
Number of subjects: 225

Group type: COMPARATOR
Intervention: 20% oxygen partial pressure (n = 61)
Number of subjects: 225
Study: 11468025

Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) using Bayesian methodology
Number of subjects: 236

Group type: COMPARATOR
Intervention: Loading dose (LD) of 25 mg/kg body weight
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Calculated dose (CD)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) in ventilated patients
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) in patients with SAPS > 35
Number of subjects: 236
Study: 9706734

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) adjunctive therapy
Number of subjects: 0
Study: 8156738

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (10 ng min‐1 100 ml‐1 forearm volume)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (equipotent vasodilator dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3279775

Group type: EXPERIMENTAL
Intervention: 400 mg per day of ketoconazole
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 800 mg per day of ketoconazole
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 1,200 or 1,600 mg per day of ketoconazole
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: higher than 400 mg dosages
Number of subjects: 112
Study: 30120313

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach (NSEB)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Prescription of physical activity (PPA)
Number of subjects: 171
Study: 28746228

Group type: EXPERIMENTAL
Intervention: Simulated B‐lines of hand ultrasound with a wet foam dressing material (SG)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Real video clips of B‐lines (RG)
Number of subjects: 150
Study: 25791373

Group type: EXPERIMENTAL
Intervention: Telephone counseling by pharmacists
Number of subjects: 211

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 211
Study: 24279445

Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 16492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16492